Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC
Abroad (travel likely)RecruitingPHASE3
Conditions
Metastatic Prostate Cancer · Intermitent Anti-androgen Therapy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Urology dpt, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Contact: Principal Investigator (Lixin Hua, M.D.)
Study leads
Lixxin Hua
Principal Investigator
Urology Dpt, First Affiliated Hospital of Nanjing Medical University